首页 | 本学科首页   官方微博 | 高级检索  
     


Does digitalis work in chronic heart failure? The end of a 200-year-old controversy
Authors:Milton Packer
Affiliation:(1) Division of Cardiology, Department of Medicine, Mount Sinai School of Medicine of The City University of New York, New York, New York;(2) Division of Cardiology, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, New York
Abstract:Summary Controlled trials using modern methods of assessment in well-defined groups of patients have now convincingly demonstrated that digitalis is an effective and well-tolerated drug in patients with chronic heart failure who have left ventricular systolic dysfunction. These encouraging findings concerning digitalis, however, should not be construed to suggest that the drug should be used alone in the treatment of heart failure. Digitalis cannot adequately control the fluid retention seen in most patients with chronic heart failure; diuretics should be added to maintain sodium balance. Digitalis has not been shown to prolong life in chronic heart failure; converting-enzyme inhibitors should be added to reduce morbidity and mortality. All three drugs should be used together in the management of patients with this disorder.Dr. Packer is the recipient of a Research Career Development Award (K04-HL-01229) from the National Institutes of Health, Bethesda, Maryland.
Keywords:digitalis  left ventricular systolic failure  diuretics  congestive heart failure
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号